Prevalence of symptoms of anxiety and depression in German patients with cystic fibrosis

Chest

Volumn 138, Issue 4, 2010, Pages 929-936

  Goldbeck, Lutz ^a   Besier, Tanja ^a   Hinz, Andreas ^b   Singer, Susanne ^b   Quittner, Alexandra L ^c  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c Department of Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANXIETY; ARTICLE; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DEPRESSION; DIABETES MELLITUS; FEMALE; GERMANY; HEMOPTYSIS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PNEUMOTHORAX; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SEX RATIO; SYMPTOMATOLOGY;

EID: 77957846952     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-2940     Document Type: Article

References (41)

1. Somers JM, Goldner EM, Waraich P, Hsu L. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatry. 2006;51(2):100-113. (Pubitemid 43304998)
2. Jacobi F, Wittchen H-U, Hölting C, et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med. 2004;34(4):597-611.
3. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19.
4. Compton WM, Conway KP, Stinson FS, Grant BF. Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002. Am J Psychiatry. 2006;163(12):2141-2147.
5. Wittchen HU, Pittrow D. Prevalence, recognition and management of depression in primary care in Germany: the Depression 2000 study. Human Psychopharmacol. 2002;17(Suppl 1):S1-S11.
6. Riolo SA, Nguyen TA, Greden JF, King CA. Prevalence of depression by race/ethnicity: findings from the National Health and Nutrition Examination Survey III. Am J Public Health. 2005;95(6):998-1000.
7. World Health Organization. http://www.who.int/mental-health/management/ depression/definition/en/. Accessed December 8, 2009.
8. Katon W, Ciechanowski P. Impact of major depression on chronic medical illness. J Psychosom Res. 2002;53(4):859-863.
9. Egede LE. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry. 2007;29(5):409-416.
10. Roy-Byrne PP, Davidson KW, Kessler RC, et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry. 2008;30(3):208-225.
11. van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 1999;54(8):688-692.
12. Singer HK, Ruchinskas RA, Riley KC, Broshek DK, Barth JT. The psychological impact of end-stage lung disease. Chest. 2001;120(4):1246-1252.
13. Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med. 2003;65(6):963-970.
14. Quittner AL, Barker DH, Snell C, Grimley ME, Marciel K, Cruz I. Prevalence and impact of depression in cystic fibrosis. Curr Opin Pulm Med. 2008;14(6):582-588.
15. US Cystic Fibrosis Foundation. www.cff.org/UploadedFiles/research/ ClinicalResearch/2008-Patient-Registry-Report.pdf. Accessed January 28, 2010.
16. Sawicki GS, Sellers DE, Robinson WM. Self-reported physical and psychological symptom burden in adults with cystic fibrosis. J Pain Symptom Manage. 2008;35(4):372-380.
17. Pfeffer PE, Pfeffer JM, Hodson ME. The psychosocial and psychiatric side of cystic fibrosis in adolescents and adults. J Cyst Fibros. 2003;2(2):61-68.
18. Riekert KA, Bartlett SJ, Boyle MP, Krishnan JA, Rand CS. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest. 2007;132(1):231-237.
19. Havermans T, Colpaert K, Dupont LJ. Quality of life in patients with cystic fibrosis: association with anxiety and depression. J Cyst Fibros. 2008;7(6):581-584.
20. Thompson RJ Jr, Hodges K, Hamlett KW. A matched comparison of adjustment in children with cystic fibrosis and psychiatrically referred and nonreferred children. J Pediatr Psychol. 1990;15(6):745-759.
21. Thompson RJ Jr, Gustafson KE, Gil KM, Godfrey J, Murphy LM. Illness specific patterns of psychological adjustment and cognitive adaptational processes in children with cystic fibrosis and sickle cell disease. J Clin Psychol. 1998;54(1):121-128.
22. Smith BA, Modi AC, Quittner AL, et al. Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance. Pediatr Pulmonol. 2010;45(8):756-763.
23. Hinz A, Schwarz R. Anxiety and depression in the general population: standardised values of the hospital anxiety and depression scale. Psychother Psychosom Med Psychol. 2001;51(5):193-200.
24. Herrmann-Lingen C, Buss U, Snaith RP. HADS-D. Hospital Anxiety and Depression Scale - Deutsche Version. Ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin. 2nd ed. Bern, Germany: Verlag Hans Huber; 2005.
25. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69-77.
26. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. J Psychosom Res. 1997;42(1):17-41.
27. Snaith RP. The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes. 2003;1:29.
28. White D, Leach C, Sims R, Atkinson M, Cottrell D. Validation of the Hospital Anxiety and Depression Scale for use with adolescents. Br J Psychiatry. 1999;175:452-454.
29. Bortz J, Döring N. Forschungsmethoden und Evaluation für Human-und Sozialwissenschaftler. 4. Heidelberg, Germany: Springer-Verlag; 2006.
30. Bussing R, Burket RC, Kelleher ET. Prevalence of anxiety disorders in a clinic-based sample of pediatric asthma patients. Psychosomatics. 1996;37(2):108-115.
31. Goodwin RD, Fergusson DM, Horwood LJ. Asthma and depressive and anxiety disorders among young persons in the community. Psychol Med. 2004;34(8):1465-1474.
32. Janson C, Björnsson E, Hetta J, Boman G. Anxiety and depression in relation to respiratory symptoms and asthma. Am J Respir Crit Care Med. 1994;149(4 Pt 1):930-934.
33. White T, Miller J, Smith GL, McMahon WM. Adherence and psychopathology in children and adolescents with cystic fibrosis. Eur Child Adolesc Psychiatry. 2009;18(2):96-104.
34. Burker EJ, Sedway J, Carone S. Psychological and educational factors: better predictors of work status than FEV1 in adults with cystic fibrosis. Pediatr Pulmonol. 2004;38(5):413-418.
35. Quittner AL, Drotar D, Seidner D, et al. Adherence to medical treatments in adolescents with cystic fibrosis: the development and evaluation of family-based interventions. In: Drotar D, ed. Promoting Adherence to Medical Treatments in Childhood Chronic Illness: Concepts, Methods, and Interventions. Mahwah, NJ: Lawrence Erlbaum Associates; 2000:383-407.
36. Jorm AF. Does old age reduce the risk of anxiety and depression? A review of epidemiological studies across the adult life span. Psychol Med. 2000;30(1):11-22.
37. Stordal E, Mykletun A, Dahl AA. The association between age and depression in the general population: a multivariate examination. Acta Psychiatr Scand. 2003;107(2):132-141.
38. Arrington-Sanders R, Yi MS, Tsevat J, Wilmott RW, Mrus JM, Britto MT. Gender differences in health-related quality of life of adolescents with cystic fibrosis. Health Qual Life Outcomes. 2006;4:5.
39. Besier T, Schmitz TG, Goldbeck L. Life satisfaction of adolescents and adults with cystic fibrosis: impact of partnership and gender. J Cyst Fibros. 2009;8(2):104-109.
40. Goldbeck L, Zerrer S, Schmitz TG. Monitoring quality of life in outpatients with cystic fibrosis: feasibility and longitudinal results. J Cyst Fibros. 2007;6(3):171-178.
41. Nici L, Donner C, Wouters E, et al; ATS/ERS Pulmonary Rehabilitation Writing Committee. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390-1413.